Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301

PaperCitations, authors & open-access status

Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 9 citations, 2004 year and closed oa status.

9
Citations
2004
Year
closed
OA Status

Related on ScholarIQ

F Mizorogi
Author
International Journal of Hematology
Journal
Multiple Myeloma Research and Treatments
Topic
Multiple Myeloma Research and Treatments
Topic
Cancer Treatment and Pharmacology
Topic
Cancer therapeutics and mechanisms
Topic
470M+ articles · free account